Literature DB >> 28396474

Evaluating the frequency of asymptomatic Ebola virus infection.

Placide Mbala1,2, Marc Baguelin3,4, Ipos Ngay1,2, Alicia Rosello5,6, Prime Mulembakani2, Nikolaos Demiris7, W John Edmunds4, Jean-Jacques Muyembe1.   

Abstract

The potential for asymptomatic infection from Ebola viruses has long been questioned. Knowing the proportion of infections that are asymptomatic substantially changes the predictions made by mathematical models and alters the corresponding decisions based upon these models. To assess the degree of asymptomatic infection occurring during an Ebola virus disease (EVD) outbreak, we carried out a serological survey in the Djera district of the Equateur province of the Democratic Republic of the Congo affected by an Ebola outbreak in 2014. We sampled all asymptomatic residents (n = 182) of 48 households where at least one case of EVD was detected. To control for potential background seroprevalence of Ebola antibodies in the population, we also sampled 188 individuals from 92 households in an unaffected area with a similar demographic background. We tested the sera collected for anti-Ebola IgG and IgM antibodies at four different dilutions. We then developed a mixture model to estimate the likely number of asymptomatic patients who developed IgM and IgG responses to Ebola antigens in both groups. While we detected an association between medium to high titres and age, we did not detect any evidence of increased asymptomatic infection in the individuals who resided in the same household as cases.This article is part of the themed issue 'The 2013-2016 West African Ebola epidemic: data, decision-making and disease control'.
© 2017 The Author(s).

Entities:  

Keywords:  Ebola virus disease; asymptomatic infection; household survey; serology

Mesh:

Substances:

Year:  2017        PMID: 28396474      PMCID: PMC5394641          DOI: 10.1098/rstb.2016.0303

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  22 in total

1.  A statistically defined endpoint titer determination method for immunoassays.

Authors:  A Frey; J Di Canzio; D Zurakowski
Journal:  J Immunol Methods       Date:  1998-12-01       Impact factor: 2.303

2.  An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.

Authors:  Shipo Wu; Andrea Kroeker; Gary Wong; Shihua He; Lihua Hou; Jonathan Audet; Haiyan Wei; Zhe Zhang; Lisa Fernando; Geoff Soule; Kaylie Tran; Shengli Bi; Tao Zhu; Xuefeng Yu; Wei Chen; Xiangguo Qiu
Journal:  J Infect Dis       Date:  2016-08-04       Impact factor: 5.226

3.  The Ebola emergency--immediate action, ongoing strategy.

Authors:  Jeremy J Farrar; Peter Piot
Journal:  N Engl J Med       Date:  2014-09-22       Impact factor: 91.245

4.  Ebola virus disease in the Democratic Republic of Congo.

Authors:  Gaël D Maganga; Jimmy Kapetshi; Nicolas Berthet; Benoît Kebela Ilunga; Felix Kabange; Placide Mbala Kingebeni; Vital Mondonge; Jean-Jacques T Muyembe; Eric Bertherat; Sylvie Briand; Joseph Cabore; Alain Epelboin; Pierre Formenty; Gary Kobinger; Licé González-Angulo; Ingrid Labouba; Jean-Claude Manuguerra; Jean-Marie Okwo-Bele; Christopher Dye; Eric M Leroy
Journal:  N Engl J Med       Date:  2014-10-15       Impact factor: 91.245

5.  Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978.

Authors:  D L Heymann; J S Weisfeld; P A Webb; K M Johnson; T Cairns; H Berquist
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

6.  Human asymptomatic Ebola infection and strong inflammatory response.

Authors:  E M Leroy; S Baize; V E Volchkov; S P Fisher-Hoch; M C Georges-Courbot; J Lansoud-Soukate; M Capron; P Debré; J B McCormick; A J Georges
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

7.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

8.  High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

Authors:  Pierre Becquart; Nadia Wauquier; Tanel Mahlakõiv; Dieudonné Nkoghe; Cindy Padilla; Marc Souris; Benjamin Ollomo; Jean-Paul Gonzalez; Xavier De Lamballerie; Mirdad Kazanji; Eric M Leroy
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

9.  Immunoglobulin G in Ebola outbreak survivors, Gabon.

Authors:  Nadia Wauquier; Pierre Becquart; Clélia Gasquet; Eric M Leroy
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

10.  Infectious disease: tough choices to reduce Ebola transmission.

Authors:  Christopher J M Whitty; Jeremy Farrar; Neil Ferguson; W John Edmunds; Peter Piot; Melissa Leach; Sally C Davies
Journal:  Nature       Date:  2014-11-13       Impact factor: 49.962

View more
  8 in total

1.  The 2013-2016 Ebola epidemic: multidisciplinary success conceals a missed opportunity.

Authors:  Cordelia E M Coltart; W John Edmunds; Katherine E Atkins
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

2.  Mapping a Filoviral Serologic Footprint in the Democratic Republic of the Congo: Who Goes There?

Authors:  Ian Crozier
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

3.  Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.

Authors:  Anna Bratcher; Nicole A Hoff; Reena H Doshi; Adva Gadoth; Megan Halbrook; Patrick Mukadi; Kamy Musene; Benoit Ilunga-Kebela; D'Andre Spencer; Matthew S Bramble; David McIlwan; J Daniel Kelly; Daniel Mukadi; Placide Mbala Kingebeni; Steve Ahuka; Emile Okitolonda-Wemakoy; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  PLoS Negl Trop Dis       Date:  2021-08-12

4.  Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak.

Authors:  Tracey Goldstein; Manjunatha N Belaganahalli; Eddy K Syaluha; Jean-Paul K Lukusa; Denise J Greig; Simon J Anthony; Alexandre Tremeau-Bravard; Riddhi Thakkar; Adrian Caciula; Nischay Mishra; W Ian Lipkin; Jasjeet K Dhanota; Brett R Smith; Victoria M Ontiveros; Nistara Randhawa; Michael Cranfield; Christine K Johnson; Kirsten V Gilardi; Jonna A K Mazet
Journal:  One Health Outlook       Date:  2020-11-04

5.  Rigorous surveillance is necessary for high confidence in end-of-outbreak declarations for Ebola and other infectious diseases.

Authors:  Robin N Thompson; Oliver W Morgan; Katri Jalava
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-08       Impact factor: 6.237

Review 6.  Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion.

Authors:  Michelle L Pleet; Catherine DeMarino; Spencer W Stonier; John M Dye; Steven Jacobson; M Javad Aman; Fatah Kashanchi
Journal:  Viruses       Date:  2019-05-02       Impact factor: 5.048

7.  Characterization and analytical validation of a new antigenic rapid diagnostic test for Ebola virus disease detection.

Authors:  Céline Couturier; Atsuhiko Wada; Karen Louis; Maxime Mistretta; Benoit Beitz; Moriba Povogui; Maryline Ripaux; Charlotte Mignon; Bettina Werle; Adrien Lugari; Delphine Pannetier; Sabine Godard; Anne Bocquin; Stéphane Mely; Ismaël Béavogui; Jean Hébélamou; David Leuenberger; Philippe Leissner; Takeshi Yamamoto; Patrick Lécine; Christophe Védrine; Julie Chaix
Journal:  PLoS Negl Trop Dis       Date:  2020-01-17

8.  A flexible format LAMP assay for rapid detection of Ebola virus.

Authors:  Laura C Bonney; Robert J Watson; Gillian S Slack; Andrew Bosworth; Nadina I Vasileva Wand; Roger Hewson
Journal:  PLoS Negl Trop Dis       Date:  2020-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.